GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Other Long-Term Liabilities

Duopharma Biotech Bhd (XKLS:7148) Other Long-Term Liabilities : RM13.2 Mil (As of Sep. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Other Long-Term Liabilities?

Duopharma Biotech Bhd's other long-term liabilities for the quarter that ended in Sep. 2023 was RM13.2 Mil.

Duopharma Biotech Bhd's quarterly other long-term liabilities increased from Mar. 2023 (RM11.5 Mil) to Jun. 2023 (RM12.2 Mil) and increased from Jun. 2023 (RM12.2 Mil) to Sep. 2023 (RM13.2 Mil).

Duopharma Biotech Bhd's annual other long-term liabilities declined from Dec. 2020 (RM10.4 Mil) to Dec. 2021 (RM9.5 Mil) and declined from Dec. 2021 (RM9.5 Mil) to Dec. 2022 (RM5.6 Mil).


Duopharma Biotech Bhd Other Long-Term Liabilities Historical Data

The historical data trend for Duopharma Biotech Bhd's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Other Long-Term Liabilities Chart

Duopharma Biotech Bhd Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Duopharma Biotech Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Duopharma Biotech Bhd Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Duopharma Biotech Bhd Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd (XKLS:7148) Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines